Marrone

Elicit Plant Appoints Pam Marrone and Johan de Saegher on Its Board of Directors

Retrieved on: 
Wednesday, March 1, 2023
Research, Environment, Professional Services, Sustainability, Other Natural Resources, Agriculture, Natural Resources, Science, Other Science, Other Professional Services, Knowledge, Eastman Chemical Company, Crop protection, Climate change, Invasive, NRDC, Criminal defense lawyer, Agricultural research in Israel, NYSE, Farmer, Laboratory, American Chemical Society, Organizational founder, Natural Resources Defense Council, Marrone, Growth, American City Business Journals, Planned Parenthood 2015 undercover videos controversy, Plant, MBI, Chairperson, Multimedia, Independent Board for Presbyterian Foreign Missions, Food, EPA, Rare-earth element, Management

Elicit Plant, an agricultural biotechnology company specialized in crops’ resistance to water stress based on a phytosterol-based technology platform, announced today it has appointed Dr. Pam Marrone as Chairwoman of the Board of Directors and Dr. Johan de Saegher as Independent Board Member.

Key Points: 
  • Elicit Plant, an agricultural biotechnology company specialized in crops’ resistance to water stress based on a phytosterol-based technology platform, announced today it has appointed Dr. Pam Marrone as Chairwoman of the Board of Directors and Dr. Johan de Saegher as Independent Board Member.
  • View the full release here: https://www.businesswire.com/news/home/20230301005582/en/
    Pam Marrone and Johan de Saegher join Elicit Plant's Board of Directors (Photo: Elicit Plant)
    Pam is a serial entrepreneur bringing over 30 years of leadership experience in the agricultural biologicals industry.
  • Pam currently serves as Executive Chair of Invasive Species Control Corporation which she cofounded in 2022.
  • Recently, she was Chief Executive Officer of Marrone Bio Innovations (MBI), an agricultural biological company she founded in 2006.

FBFK Attorneys Mackey Culbertson, Ryan Marrone Promoted to Shareholder

Retrieved on: 
Wednesday, January 25, 2023
Lawyer, D Magazine, Marrone, Employment, Bankruptcy, Corporate law, Scottish Politician of the Year, Insurance, Patent, Practice of law, DALLAS

DALLAS, Jan. 25, 2023 /PRNewswire-PRWeb/ -- Leadership from Dallas-based FBFK law firm is pleased to announce the elevation of Transactional/M&A attorney Mackey Culbertson and Commercial Litigation attorney Ryan Marrone to shareholder.

Key Points: 
  • Dallas-based FBFK law firm announced the elevation of Transactional/M&A attorney Mackey Culbertson and Commercial Litigation attorney Ryan Marrone to shareholder.
  • DALLAS, Jan. 25, 2023 /PRNewswire-PRWeb/ -- Leadership from Dallas-based FBFK law firm is pleased to announce the elevation of Transactional/M&A attorney Mackey Culbertson and Commercial Litigation attorney Ryan Marrone to shareholder.
  • "Mackey and Ryan are stellar attorneys who have played an important role in FBFK's success over the past several years," says FBFK CEO Kyle Ferguson.
  • "They have both earned the shareholder rank and we anticipate great things from them in the years ahead."

FBFK Attorneys Honored By 2023 The Best Lawyers in America©

Retrieved on: 
Thursday, August 18, 2022
Tax law, SEC, Alcohol, Board, American Bankruptcy Institute, American College, Ones to Watch, IRS, Lawyer, MATCH International Women's Fund, State Bar of Texas, City, Insolvency, Law, Dedman School of Law, Tex, Patent, TMA, Trade, Marrone, D Magazine, Texas College, Private practice, Bankruptcy, Baylor Law School, Chair, Bar association, DFW, Intellectual property, Texas Board of Legal Specialization, Real estate, The Council, Corporate law, Southern Methodist University, Tory Baucum, Organization, Trust, Silicon, ABI, Chapter 11, Title 11, United States Code, Review, Federal court, Global, Methodist University, F. W. Kubasta, Practice of law, Insurance, DALLAS

DALLAS, Aug. 18, 2022 /PRNewswire-PRWeb/ -- The 2023 Best Lawyers in America© report, based solely on peer review and the "gold standard" in the legal industry, announced that four attorneys at DFW-based FBFK law firm were included in this year's edition. Dan Baucum, Kelly Kubasta, Richard Spencer and Kenn Webb were recognized among their peers worldwide for expertise in their respective practice areas. Additionally, Rachael Smiley and Ryan Marrone were recognized as "Ones to Watch."

Key Points: 
  • The 2023 Best Lawyers in America report named four attorneys at DFW-based FBFK law firm to this year's edition, including Dan Baucum, Kelly Kubasta, Richard Spencer and Kenn Webb.
  • DALLAS, Aug. 18, 2022 /PRNewswire-PRWeb/ -- The 2023 Best Lawyers in America report, based solely on peer review and the "gold standard" in the legal industry, announced that four attorneys at DFW-based FBFK law firm were included in this year's edition.
  • Published in more than 70 countries around the world for 41 years, The Best Lawyers in America recognizes top legal talent and only lawyers recognized in the current edition are eligible to vote for the upcoming edition.
  • Kubasta is a nine-time The Best Lawyers in America honoree, recently served as a Board Member of TeXchange DFW, and works with various non-profit organizations.

MARRONE BIO INVESTOR ALERT - Kuznicki Law PLLC Investigates Proposed Sale of Marrone Bio Innovations, Inc. - MBII

Retrieved on: 
Wednesday, May 4, 2022
Legal, Professional Services, Company, Nasdaq, MBII, Sale, Marrone, Security (finance)

Kuznicki Law PLLC is investigating the proposed sale of Marrone Bio Innovations, Inc. (NasdaqCM: MBII) to Bioceres Crop Solutions Corp. (NasdaqGS: BIOX).

Key Points: 
  • Kuznicki Law PLLC is investigating the proposed sale of Marrone Bio Innovations, Inc. (NasdaqCM: MBII) to Bioceres Crop Solutions Corp. (NasdaqGS: BIOX).
  • Under the terms of the proposed transaction, shareholders of Marrone will receive only 0.088 shares of Bioceres for each share of Marrone that they own.
  • If you would like to discuss your legal rights regarding the proposed sale, you may, without obligation or cost to you, contact us toll free at 833-938-0905, via email ( [email protected] ), or visit https://kclasslaw.com/cases/ma/nasdaqcm-mbii/ to learn more.
  • Kuznicki Law PLLC is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship.

MARRONE BIO INVESTOR ALERT by The Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Marrone Bio Innovations, Inc. - MBII

Retrieved on: 
Wednesday, April 27, 2022
Legal, Professional Services, Company, KSF, Sale, Marrone, MBII, Nasdaq, LLC

and the law firm of Kahn Swick & Foti, LLC (KSF) are investigating the proposed sale of Marrone Bio Innovations, Inc. (NasdaqCM: MBII) to Bioceres Crop Solutions Corp. (NasdaqGS: BIOX).

Key Points: 
  • and the law firm of Kahn Swick & Foti, LLC (KSF) are investigating the proposed sale of Marrone Bio Innovations, Inc. (NasdaqCM: MBII) to Bioceres Crop Solutions Corp. (NasdaqGS: BIOX).
  • Under the terms of the proposed transaction, shareholders of Marrone will receive only 0.088 shares of Bioceres for each share of Marrone that they own.
  • KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the consideration undervalues the Company.
  • To learn more about KSF, whose partners include the Former Louisiana Attorney General, visit www.ksfcounsel.com .

MARRONE BIO INVESTOR ALERT by The Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Marrone Bio Innovations, Inc. - MBII

Retrieved on: 
Saturday, March 19, 2022
Legal, Professional Services, Company, Nasdaq, LLC, Sale, Marrone, MBII, KSF

and the law firm of Kahn Swick & Foti, LLC (KSF) are investigating the proposed sale of Marrone Bio Innovations, Inc. (NasdaqCM: MBII) to Bioceres Crop Solutions Corp. (NasdaqGS: BIOX).

Key Points: 
  • and the law firm of Kahn Swick & Foti, LLC (KSF) are investigating the proposed sale of Marrone Bio Innovations, Inc. (NasdaqCM: MBII) to Bioceres Crop Solutions Corp. (NasdaqGS: BIOX).
  • Under the terms of the proposed transaction, shareholders of Marrone will receive only 0.088 shares of Bioceres for each share of Marrone that they own.
  • KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the consideration undervalues the Company.
  • To learn more about KSF, whose partners include the Former Louisiana Attorney General, visit www.ksfcounsel.com .

FBFK Commercial Litigation Attorney Ryan Marrone Named to D Magazine's 2022 "Best Lawyers Under 40"

Retrieved on: 
Monday, January 10, 2022
Lawyer, Public Citizen Litigation Group, COO, D Magazine, Review, Insurance, Marrone, Bankruptcy, Silicon, Employment, Patent, Real estate, Practice of law

DALLAS, Jan. 10, 2022 /PRNewswire-PRWeb/ -- Ryan Marrone, an experienced commercial litigator with the FBFK Law Firm , has been selected to D Magazine's 2022 "Best Lawyers Under 40" list.

Key Points: 
  • DALLAS, Jan. 10, 2022 /PRNewswire-PRWeb/ -- Ryan Marrone, an experienced commercial litigator with the FBFK Law Firm , has been selected to D Magazine's 2022 "Best Lawyers Under 40" list.
  • Selected attorneys are featured in the January 2022 issue of D Magazine.
  • "In my 35 years of legal practice, I have not seen a better young attorney," said Jim Davis, COO and Chair of FBFK's Litigation Group.
  • An experienced commercial litigator, Marrone represents clients in complex disputes and regularly opposes Am Law 100 firms.

Marrone Bio Innovations Issues Shareholder Letter

Retrieved on: 
Wednesday, April 28, 2021
Environmentalism, Sustainability, Marrone, Microorganism, Articles, Natural environment

This is a key time of year for Marrone Bio as well, as our products are rapidly moving through the distribution channel to the farm.

Key Points: 
  • This is a key time of year for Marrone Bio as well, as our products are rapidly moving through the distribution channel to the farm.
  • We also are raising our annual gross margin target to the upper 50% range.
  • The start to the growing season in Europe also looks strong, with a rebound expected for both cereal and oilseed planted areas.
  • The company\xe2\x80\x99s research and development program uses proprietary technologies to isolate and screen naturally occurring microorganisms and plant extracts to create new, sustainable solutions in agriculture.\nLearn more about Marrone Bio Innovations at www.marronebio.com .

Marrone Bio Innovations Issues Shareholder Letter

Retrieved on: 
Tuesday, March 23, 2021
Economy of New York City, NASDAQ, Marrone, Finance

DAVIS, Calif., March 23, 2021 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ: MBII) (Marrone Bio), an international leader in providing growers with sustainable bioprotection and plant health solutions to support global agricultural needs, today released a letter to shareholders from Chief Executive Officer, Kevin Helash.

Key Points: 
  • DAVIS, Calif., March 23, 2021 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ: MBII) (Marrone Bio), an international leader in providing growers with sustainable bioprotection and plant health solutions to support global agricultural needs, today released a letter to shareholders from Chief Executive Officer, Kevin Helash.
  • Marrone Bio Innovations Inc.(NASDAQ: MBII) is a growth-oriented agricultural company leading the movement to a more sustainable world through the discovery, development and sale of innovative biological products for crop protection, crop health and crop nutrition.
  • Learn more about Marrone Bio Innovations at www.marronebio.com .
  • This letter contains forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995.

Marrone Bio Innovations, Inc. Reports Fourth-Quarter and Full-Year 2020 Financial Results

Retrieved on: 
Tuesday, March 23, 2021
Marrone, Net operating loss

The fourth-quarter net loss was $4.2 million as compared with a net loss of $10.1 million in the fourth quarter of 2019.

Key Points: 
  • The fourth-quarter net loss was $4.2 million as compared with a net loss of $10.1 million in the fourth quarter of 2019.
  • The improvement was driven by the gains in revenues and gross profit, coupled with the benefits from cost management.
  • We remain committed to our mission of rapidly advancing Marrone Bio toward profitability, and the results this year supported this objective, said Chief Executive Officer Kevin Helash.
  • ET (1:30 p.m. PT) on March 23, 2021 to discuss Marrone Bio Innovations fourth quarter and full year 2020 financial results, provide a corporate update, and conclude with a Q&A from participants.